Share Twitter LinkedIn Facebook Email Debra Patt, MD, MPH, MBA, VP of Texas Oncology discusses why she has not been incorporating liquid biopsies into patient management at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read